NCT00991796 CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00989261 Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE2
NCT00986440 Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Status TERMINATED Phase PHASE2
NCT00986154 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). Status COMPLETED Phase PHASE3
NCT00969033 CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin Status TERMINATED Phase PHASE2
NCT00967616 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy Status COMPLETED Phase PHASE2
NCT00951899 The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics Status COMPLETED Phase PHASE4
NCT00945191 Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00938405 Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus Status COMPLETED Phase NA
NCT00923091 Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension Status COMPLETED Phase PHASE3
NCT00902538 Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension Status COMPLETED Phase PHASE3
NCT00890591 Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension Status COMPLETED Phase PHASE4
NCT00881569 Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017 Status COMPLETED Phase PHASE1
NCT00872586 Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension Status COMPLETED Phase PHASE3
NCT00857285 Olmesartan Medoxomil Versus Losartan in Patients With Hypertension Status COMPLETED Phase PHASE3
NCT00856271 Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension Status COMPLETED Phase PHASE3
NCT00806286 Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2